Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Peters

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pharmacology|August 1, 1994
Lack of a pharmacokinetic/pharmacodynamic interaction between nimodipine and tirilazad mesylate in healthy volunteersJ C Fleishaker, L K Hulst, G R Peters
Pharmaceutical Research|February 1, 1994
Lack of pharmacokinetic interaction between cimetidine and tirilazad mesylateJ C Fleishaker, L K Hulst, G R Peters
Biopharmaceutics & Drug Disposition|April 9, 1998
Induction of tirilazad clearance by phenytoinJ C Fleishaker, L K Pearson, G R Peters
European Journal of Clinical Pharmacology|January 1, 1996
Gender does not affect the degree of induction of tirilazad clearance by phenobarbitalJ C Fleishaker, L K Pearson, G R Peters
Clinical Pharmacology and Therapeutics|October 1, 1994
The effect of phenytoin on the pharmacokinetics of tirilazad mesylate in healthy male volunteersJ C Fleishaker, L K Hulst, G R Peters
Critical Reviews in Clinical Laboratory Sciences|December 1, 1996
Environmental aspects of arsenic toxicityG R Peters, R F McCurdy, J T Hindmarsh
European Journal of Clinical Pharmacology|January 1, 1996
Comparison of the pharmacokinetics of tirilazad mesylate in healthy volunteers and stable subjects with mild liver cirrhosisL K Pearson, J C Fleishaker, G R Peters
Antimicrobial Agents and Chemotherapy|October 1, 1990
Pharmacokinetics and dose proportionality of cefmetazole in healthy young and elderly volunteersM T Borin, G R Peters, T C Smith
Journal of Gerontology|July 1, 1979
The voluntary associations of the agedN Babchuk, G R Peters, D R Hoyt, et al.
Journal of Gerontology|November 1, 1980
Life satisfaction and activity theory: a multidimensional approachD R Hoyt, M A Kaiser, G R Peters, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|August 1, 1994
Lack of a pharmacokinetic/pharmacodynamic interaction between nimodipine and tirilazad mesylate in healthy volunteersJ C Fleishaker, L K Hulst, G R Peters
Pharmaceutical Research|February 1, 1994
Lack of pharmacokinetic interaction between cimetidine and tirilazad mesylateJ C Fleishaker, L K Hulst, G R Peters
Biopharmaceutics & Drug Disposition|April 9, 1998
Induction of tirilazad clearance by phenytoinJ C Fleishaker, L K Pearson, G R Peters
European Journal of Clinical Pharmacology|January 1, 1996
Gender does not affect the degree of induction of tirilazad clearance by phenobarbitalJ C Fleishaker, L K Pearson, G R Peters
Clinical Pharmacology and Therapeutics|October 1, 1994
The effect of phenytoin on the pharmacokinetics of tirilazad mesylate in healthy male volunteersJ C Fleishaker, L K Hulst, G R Peters
Critical Reviews in Clinical Laboratory Sciences|December 1, 1996
Environmental aspects of arsenic toxicityG R Peters, R F McCurdy, J T Hindmarsh
European Journal of Clinical Pharmacology|January 1, 1996
Comparison of the pharmacokinetics of tirilazad mesylate in healthy volunteers and stable subjects with mild liver cirrhosisL K Pearson, J C Fleishaker, G R Peters
Antimicrobial Agents and Chemotherapy|October 1, 1990
Pharmacokinetics and dose proportionality of cefmetazole in healthy young and elderly volunteersM T Borin, G R Peters, T C Smith
Journal of Gerontology|July 1, 1979
The voluntary associations of the agedN Babchuk, G R Peters, D R Hoyt, et al.
Journal of Gerontology|November 1, 1980
Life satisfaction and activity theory: a multidimensional approachD R Hoyt, M A Kaiser, G R Peters, et al.
Pageof 6